March is Ovarian Cancer Awareness Month in the UK, and to commemorate it, Informa Pharma Intelligence is offering 20% off select ovarian cancer reports at the Report Store. Dive deeply into market data and the outlook for ovarian cancer, the deadliest form of gynecological cancer for women in the western world.

Just use the code ovarian20 at the Report Store for a 20% discount on the following reports:

Related Reports

Ovarian cancer medicines have traditionally been subject to low restrictions, as most patients usually start and remain on inexpensive platinum-based therapies.

Ovarian cancer is defined as a group of tumors that originate in the ovaries. Epithelial ovarian cancer is the prevailing cause of death from gynecological malignancies in the Western world. Patients with early-stage disease have a very good prognosis, with five-year recurrence-free survival of 75–80%. However, most patients present with advanced disease at diagnosis and, despite high responses to initial treatment, the majority will eventually recur with incurable disease.